ArticleVaccine2022

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).

Brett Leav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.